Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
24-hour tranexamic acid regimens for prevention of SIRS and postoperative bleeding after cardiopulmonary bypass
ISRCTN84413719Phase 4Completed
- Sponsor
- Hospital Universitario de Canarias
- Start
- Dec 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of tranexamic acid in Systemic Inflammatory Response Syndrome (SIRS) and postoperative hemorrhage (2 arms), sponsored by Hospital Universitario de Canarias. Primary endpoint: Biochemical determinations and haemodynamic parameters. Started Dec 2005; status: completed.
02
Drugs
tranexamic acid
03
Conditions
Systemic Inflammatory Response Syndrome (SIRS)postoperative hemorrhage
Beyond the preview
Go deeper on ISRCTN84413719.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN84413719.